Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D05YHW
|
|||
| Former ID |
DIB008180
|
|||
| Drug Name |
Vapaliximab
|
|||
| Synonyms |
Huvap; HuvapR; BTT-1002; Chimeric VAP-1 monoclonal antibody (inflammation), BioTie; Chimeric VAP-1 mAb (inflammation), BioTie/Seikagaku
Click to Show/Hide
|
|||
| Drug Type |
Antibody
|
|||
| Indication | Inflammation [ICD-11: 1A00-CA43.1] | Terminated | [1] | |
| Company |
BioTie Therapies Corp
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Membrane copper amine oxidase (AOC3) | Target Info | . | [2] |
| BioCyc | Phenylethylamine degradation I | |||
| Spermine and spermidine degradation I | ||||
| KEGG Pathway | Glycine, serine and threonine metabolism | |||
| Tyrosine metabolism | ||||
| Phenylalanine metabolism | ||||
| beta-Alanine metabolism | ||||
| Metabolic pathways | ||||
| Panther Pathway | Phenylethylamine degradation | |||
| Pathwhiz Pathway | Beta-Alanine Metabolism | |||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800017603) | |||
| REF 2 | Clinical pipeline report, company report or official report of Huginonline. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.